Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of Bcl inhibitors for the prevention of fibroproliferative reclosure of dilated blood vessels and other iatrogenic fibroproliferative disorders

Use of Bcl inhibitors for the prevention of fibroproliferative reclosure of dilated blood vessels and other iatrogenic fibroproliferative disorders

US Patent 7857804 · Granted Dec 28, 2010

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Communication method, apparatus, and system2025
Blood biomarkers for appendicitis and diagnostics methods using biomarkers2025
Blood RNA biomarkers of coronary artery disease2024
Blood biomarkers for respiratory infections2023
Blood biomarkers for appendicitis and diagnostics methods using biomarkers2022
Blood biomarkers for appendicitis and diagnostics methods using biomarkers2021
Blood biomarkers for respiratory infections2020
Prediction of bare metal stent restenosis2009
Method for the treatment of fibroproliferative disorders by application of inhib2000
Method for the treatment of conditions mediated by collagen formation together w2000
Method for the treatment of fibroproliferative disorders by application of inhib1999
Method for the treatment of fibroproliferative disorders by application of inhib1999